Petra van Vlierberghe

Petra Van Vlierberghe started their work experience in 1996 as a CRA at ClinTrials research. Petra then joined PAREXEL in 1998 as an Associate Project Director and stayed with the company until 2007. In 2007, they moved to PRA and worked as a Project Director for a year. From 2008 to 2012, they held the role of Project Director at PAREXEL. Petra then progressed to the position of Portfolio Director from 2013 to 2014, and subsequently became a Senior Portfolio Director from 2014 to 2017. From 2018 to 2020, Petra worked at Parexel as the Global Head Integrated Solutions, Oncology, and Hematology. Currently, they are the VP and Head of Global Clinical Operations at argenx, starting in 2020.

Petra Van Vlierberghe attended Ghent University from 1990 to 1995, where they earned a degree in Bio-Engineering in chemistry. Petra'sfield of study was chemistry engineering, with a focus on human nutrition. Additionally, they had an experience with AFS US, but no specific details about their degree or field of study were provided.